Mukka Proteins board approved a strategic cash investment of ₹64,92,500 in Swachha Eco Solutions Private Limited during a meeting held on August 12, 2026. The company plans to acquire 26,500 equity shares at ₹250 per share, securing a 25.98% stake in the investee entity. This move aligns with Mukka Proteins’ strategy to expand its presence in the waste management sector.

The acquisition is structured as an arm’s length transaction and does not involve any related parties, promoters, or group companies. Mukka Proteins intends to complete the acquisition by December 31, 2026, through one or more tranches. No governmental or regulatory approvals are required for this deal.

Investment Details

Target Company Profile

Swachha Eco Solutions Private Limited operates in the collection, treatment, and disposal of all types of waste. Incorporated on September 12, 2017, the company has an authorized capital of ₹10,00,000 and a paid-up capital of ₹5,00,000.

Financial data for Swachha Eco Solutions reveals significant volatility in recent years. For FY26, the company reported a turnover of ₹1,77,61,136, down from ₹2,77,64,810 in FY25 and ₹1,44,45,028 in FY24. Despite generating revenue, the target entity posted a net loss of ₹(75,05,051) for FY26, resulting in a negative net worth of ₹(2,10,22,476) as of March 2026.

What the Numbers Show

The financial profile of Swachha Eco Solutions presents a divergence between top-line activity and profitability. While revenue fluctuated between ₹1.44 crore and ₹2.77 crore over the last three fiscal years, the company consistently operated at a loss, culminating in a negative net worth position. Mukka Proteins’ entry at a valuation implied by the ₹250 per share price suggests a strategic focus on operational turnaround or market access rather than immediate financial returns from the target’s current earnings capacity.

Mukka Proteins board of directors approved the reappointment of three independent directors and three key managerial personnel for five-year terms during a meeting held on August 12, 2026. The appointments, which commence in January 2027, are subject to shareholder approval at the company’s 16th Annual General Meeting.

The board acted on recommendations from the Nomination and Remuneration Committee to secure leadership continuity across both oversight and executive functions. The reappointments cover the period from mid-January 2027 to mid-January 2032 for independent directors, and from late January 2027 to late January 2032 for key managerial personnel.

Independent Director Reappointments

Three non-executive independent directors were approved for their second consecutive five-year terms:

• Mr. Karkala Shankar Balachandra Rao (DIN: 03589394)
• Mr. Hamad Bava (DIN: 094423)
• Mr. Narendra Surendra Kamath (DIN: 07255904)

These directors are not liable to retire by rotation. Their terms begin on January 15, 2027, and end on January 14, 2032.

Key Managerial Personnel Reappointments

Three whole-time directors and executives were also approved for five-year terms beginning January 20, 2027:

Mr. Haris, who serves as managing director and chief executive officer, is not liable to retire by rotation. Mr. Althaf, the chief financial officer, and Mr. Arif, the chief operating officer, are liable to retire by rotation.

Governance Compliance

The disclosures comply with Regulation 30(6) read with Schedule III of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The board confirmed that none of the appointees are debarred from holding office by virtue of any SEBI order or other authority.

The meeting commenced at 3:30 pm and concluded at 4:15 pm. Mehaboobsab Mahmadgous Chalyal, company secretary and compliance officer, certified the disclosure.